Concurrent placement of SpaceOAR gel and gold fiducials during HoLEP: a case report

Herein, we describe a case of a patient diagnosed with prostate cancer (PCa) who presented with lower urinary tract symptoms (LUTS) and elevated Prostate Specific Antigen (PSA). He underwent Holmium Laser Enucleation of the Prostate (HoLEP) for his severe LUTS with concurrent placement of SpaceOAR g...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganesh, Meera B., Kaplunov, Briana S., Lee, Matthew S., Assmus, Mark A., Ross, Ashley E., Coleman, Joy, Krambeck, Amy E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796108/
https://www.ncbi.nlm.nih.gov/pubmed/35096145
http://dx.doi.org/10.1177/17562872211072637
Descripción
Sumario:Herein, we describe a case of a patient diagnosed with prostate cancer (PCa) who presented with lower urinary tract symptoms (LUTS) and elevated Prostate Specific Antigen (PSA). He underwent Holmium Laser Enucleation of the Prostate (HoLEP) for his severe LUTS with concurrent placement of SpaceOAR gel and gold fiducials in preparation for radiation therapy (RT). After a successful operation, the patient underwent same-day discharge and catheter removal. He regained continence at 2 weeks and started RT at 9 weeks post-HoLEP. We present that concurrent placement of fiducials and SpaceOAR during HoLEP appears to be feasible, well tolerated and effective for PCa patients who elect RT.

Ejemplares similares